STOCK TITAN

Arcelormittal (MT) Revenue by Year

MT

Arcelormittal generated $61.4B in revenue in fiscal year 2025. This represents a decrease of 1.7% from the prior fiscal year. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Arcelormittal has filed alongside them.

FY2025 annual
Revenue $61.4B
YoY -1.7%
5Y CAGR +2.9%
10Y CAGR -0.4%
Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

MT Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-K
Revenue$61.4B-1.7%$62.4B-8.5%$68.3B-14.5%$79.8B+4.3%$76.6B+43.7%$53.3B-24.6%$70.6B-7.1%$76.0B+10.7%$68.7B+20.9%$56.8B-10.7%$63.6B

MT Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2510-KQ2'256-KQ4'2410-KQ2'2410-QQ4'2310-KQ2'2310-QQ4'2210-KQ2'2210-QQ4'2110-KQ2'2110-QQ4'2010-KQ2'2010-Q
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Arcelormittal financials

Frequently Asked Questions

What was Arcelormittal's revenue in fiscal year 2025?

Arcelormittal generated $61.4B in revenue in fiscal year 2025.

How fast is Arcelormittal's revenue growing?

Arcelormittal (MT) revenue fell by 1.7% year over year, from $62.4B to $61.4B in fiscal year 2025.

How has Arcelormittal's revenue changed over the years?

Across the 11 fiscal years this page covers, Arcelormittal (MT) revenue went from $63.6B in fiscal year 2015 to $61.4B in fiscal year 2025.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Arcelormittal (MT) reported on that line in every period on record.